Bausch & Lomb | Bausch Health | Florida | state | 2012 | $47,493 | | training reimbursement |
Bausch & Lomb | Bausch Health | Virginia | state | 2023 | $300,000 | | grant |
Bausch & Lomb | Bausch Health | Virginia | state | 2020 | $210,000 | | grant |
Bausch & Lomb Inc. | Bausch Health | New York | local | 2019 | $20,253 | | tax credit/rebate |
Bausch & Lomb Inc. | Bausch Health | New York | local | 2020 | $1,076,396 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2006 | $1,599,567 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2007 | $1,123,304 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | Massachusetts | state | 2011 | $7,623 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New Jersey | state | 2008 | $3,500,000 | | grant |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2015 | $9,000,000 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2015 | $709,291 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2009 | $1,169,891 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2010 | $1,517,457 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2005 | $680,000 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2008 | $1,187,088 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2011 | $1,490,125 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2012 | $1,416,700 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2013 | $375,037 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2016 | $446,809 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2017 | $150,152 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | Local | 2018 | $119,960 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2019 | $119,959 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2020 | $210,812 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2021 | $184,567 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2021 | $97,120 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $116,856 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $75,893 | | tax credit/rebate |
Bausch & Lomb Incorporated - Clearwater Facility | Bausch Health | Florida | state | 2005 | $135,000 | | tax credit/rebate |
Bausch & Lomb Incorporated(2) | Bausch Health | New York | state | 2019 | $3,000,000 | | tax credit/rebate |
Bausch & Lomb R&D | Bausch Health | New York | local | 2006 | $605,264 | | tax credit/rebate; property tax abatement |
BAUSH & LOMB | Bausch Health | South Carolina | state | 2010 | $615,965 | | training reimbursement |
Baxalta Us Inc | Takeda Pharmaceutical | California | state | 2022 | $20,998 | | training reimbursement |
Baxalta. Inc. | Takeda Pharmaceutical | Massachusetts | state | 2016 | $1,320,000 | | tax credit/rebate |
Bellicum Pharmaceuticals, Inc. | Bellicum Pharmaceuticals | Texas | state | 2007 | $1,450,000 | | grant |
BEN VENUE LABORATORIES | Boehringer Ingelheim | Ohio | state | 2001 | $2,439,160 | | enterprise zone |
BEN VENUE LABORATORIES | Boehringer Ingelheim | Ohio | state | 2007 | undisclosed | | enterprise zone |
BEN VENUE LABORATORIES INC | Boehringer Ingelheim | Ohio | state | 2009 | $45,000 | | grant |
BEN VENUE LABORATORIES, INC. | Boehringer Ingelheim | Ohio | state | 2005 | $2,246,703 | | enterprise zone |
BEN VENUE LABORATORIES, INC. | Boehringer Ingelheim | Ohio | state | 2006 | undisclosed | | enterprise zone |
Ben Venue Laboratories, Inc. | Boehringer Ingelheim | Ohio | state | 1999 | undisclosed | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2012 | $15,915 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2013 | $37,544 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2015 | $26,777 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2016 | $28,209 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2020 | $3,835 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2019 | $23,683 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2018 | $32,659 | | tax credit/rebate |
BioDelivery Sciences International, Inc. | BioDelivery Sciences International | North Carolina | state | 2016 | $18,708 | | tax credit/rebate |
BioDelivery Sciences International, Inc. | BioDelivery Sciences International | North Carolina | state | 2015 | $89,958 | | tax credit/rebate |
BioDelivery Sciences International, Inc. | BioDelivery Sciences International | North Carolina | state | 2018 | $1,141 | | tax credit/rebate |
Biogen | Biogen | North Carolina | state | 1995 | $120,000 | | grant |
Biogen Idec | Biogen | Massachusetts | state | 2014 | $6,250,000 | | tax credit/rebate |
Biogen Idec MA, Inc | Biogen | Massachusetts | state | 2012 | $1,836,449 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2011 | $743,297 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $45,000 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $751,067 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | Massachusetts | state | 2013 | $5,512,500 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $14,625 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $687,362 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2015 | $24,188 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2016 | $274,743 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2016 | $666,448 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2015 | $1,425,876 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2017 | $467,431 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2018 | $254,453 | | tax credit/rebate |
Biogen Idec US Limited Partnership | Biogen | North Carolina | state | 2009 | $12,564,345 | | tax credit/rebate |
Biogen Idec US Limited Partnership | Biogen | North Carolina | state | 2008 | $305,070 | | tax credit/rebate |
Biogen Idec, MA Inc. | Biogen | Massachusetts | state | 2015 | $1,440,000 | | tax credit/rebate |
BioLife Plasma Services L.P. | Takeda Pharmaceutical | Idaho | state | 2011 | $523,620 | | training reimbursement |
BioProtection Systems Corporation | Lumos Pharma | Iowa | state | 2007 | $71,101 | | training reimbursement |
BioRexis | Pfizer | Pennsylvania | state | | $250,000 | | training reimbursement |
BioRexis Pharmaceutical Corporation | Pfizer | Pennsylvania | state | | $100,000 | | grant |
BIOSENSE WEBSTER, INC. | Johnson & Johnson | California | state | 2003 | $78,520 | | training reimbursement |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $360,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $450,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2008 | | $450,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $270,000 | federal loan or loan guarantee |
Biovail Americas Corporation and subsidiaries | Bausch Health | New Jersey | state | 2013 | $39,502,500 | | tax credit/rebate |
Blueprint Medicines Corp | Blueprint Medicines | Massachusetts | state | 2013 | $45,000 | | tax credit/rebate |
Blueprint Medicines Corp | Blueprint Medicines | Massachusetts | state | 2013 | $200,000 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2012 | $60,750 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2012 | $100,000 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2017 | $525,000 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2020 | $1,065,000 | | tax credit/rebate |
BOEHRINGER INGELHEIM FREMONT INC | Boehringer Ingelheim | California | state | 2017 | $249,388 | | training reimbursement |
BOEHRINGER INGELHEIM FREMONT INC | Boehringer Ingelheim | California | state | 2019 | $343,449 | | training reimbursement |
Boehringer Ingelheim Fremont Inc | Boehringer Ingelheim | California | state | 2021 | $898,743 | | training reimbursement |
BOEHRINGER INGELHEIM FREMONT, INC. | Boehringer Ingelheim | California | state | 2014 | $248,794 | | training reimbursement |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2011 | $141,093 | | tax credit/rebate |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Connecticut | state | 2012 | $344,500 | | tax credit/rebate |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2013 | $33,421 | | tax credit/rebate |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2014 | $4,825 | | tax credit/rebate |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #2) | Hikma Pharmaceuticals | Ohio | local | 2009 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #2) | Hikma Pharmaceuticals | Ohio | local | 2010 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #2) | Hikma Pharmaceuticals | Ohio | local | 2011 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #3) | Hikma Pharmaceuticals | Ohio | local | 2009 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #3) | Hikma Pharmaceuticals | Ohio | local | 2010 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #3) | Hikma Pharmaceuticals | Ohio | local | 2011 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc./Roxane Laboratories, Inc. | Hikma Pharmaceuticals | Ohio | state | 2012 | undisclosed | | enterprise zone |
Boehringer Ingelheim Roxane, Inc.; Roxane Laboratories, Inc. | Hikma Pharmaceuticals | Ohio | local | 2012 | undisclosed | | property tax abatement |
BOEHRINGER INGELHEIM USA | Boehringer Ingelheim | Missouri | state | 2015 | $13,879 | | tax credit/rebate |